LigaChem Biosciences Inc.
Clinical-stage biopharma developing ADCs, immuno-oncology drugs, and small molecules.
141080 | KO
Overview
Corporate Details
- ISIN(s):
- KR7141080002
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 국제과학10로 10 (주)레고켐 바이오사이언스, 대전광역시
- Website:
- https://ligachembio.com/
Description
LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative medicines. Leveraging its core expertise in medicinal chemistry, the company focuses on developing Antibody-Drug Conjugates (ADCs), immuno-oncology drugs, and small molecules. A key asset is its proprietary, next-generation ADC platform technology, engineered to overcome the limitations of conventional ADC technologies. The company's pipeline includes multiple programs targeting oncology, as well as other therapeutic areas such as antibiotics and anti-fibrotics. LigaChem Biosciences actively pursues global drug development through strategic partnerships, including co-development and licensing agreements with international pharmaceutical companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-31 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.1 KB | ||
| 2025-03-31 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.4 KB | ||
| 2025-03-25 00:00 |
주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 32.9 KB | ||
| 2025-03-21 00:00 |
감사보고서제출
|
Korean | 26.0 KB | ||
| 2025-03-21 00:00 |
사업보고서 (2024.12)
|
Korean | 619.1 KB | ||
| 2025-03-14 00:00 |
투자판단관련주요경영사항 ('LCB97'관련 마일스톤 기술료 수령)
|
Korean | 8.2 KB | ||
| 2025-03-14 00:00 |
주주총회소집공고
|
Korean | 184.0 KB | ||
| 2025-03-11 00:00 |
주주총회소집결의
|
Korean | 10.8 KB | ||
| 2025-02-14 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-02-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2025-02-13 00:00 |
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 항체 기술도입 계약 체결)
|
Korean | 10.5 KB | ||
| 2025-01-20 00:00 |
신탁계약에의한취득상황보고서
|
Korean | 23.8 KB | ||
| 2025-01-06 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 55.7 KB | ||
| 2024-12-18 00:00 |
투자판단관련주요경영사항(임상시험결과) (메티실린 내성 황색포도상구균 (MRSA) 균혈증 치료제 델파졸리드(LCB01-0…
|
Korean | 10.7 KB | ||
| 2024-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all LigaChem Biosciences Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LigaChem Biosciences Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LigaChem Biosciences Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
